Mechanism

Broad anti-angiogenic activity

Assets acting on this target.

Class
PEGylated recombinant human endostatin (anti-angiogenic biologic; modality should be corrected from null to 'biologic/recombinant protein', not a small molecule)
Pathway
Tumor angiogenesis inhibition
Notes
original target text: Broad anti-angiogenic activity (endothelial cell proliferation; VEGF/bFGF signaling and integrin/heparan-sulfate proteoglycan binding), not a single discrete receptor target
Research

Explore this mechanism at different depths

Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.

Company

0 of 0 assets

No assets match these filters.

← all assets